Zwerina, Jochen

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., et al. (2012) · Nature Communications

TGF-β signaling in diseasesWnt/β-catenin signaling in development and cancer

Cited by 843

Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis

Distler, J. H. W., Jüngel, A., Huber, L. C., Schulze‐Horsel, U., Zwerina, J., Gay, R. E., Michel, B. A., Hauser, T., Schett, G., Gay, S., et al. (2007) · Arthritis & Rheumatism

Systemic Sclerosis and Related DiseasesDupuytren's Contracture and Treatments

Cited by 383

Platelet-derived serotonin links vascular disease and tissue fibrosis

Dees, C., Akhmetshina, A., Zerr, P., Reich, N., Palumbo, K., Horn, A., Jüngel, A., Beyer, C., Krönke, G., Zwerina, J., et al. (2011) · Journal of Experimental Medicine

Systemic Sclerosis and Related DiseasesTGF-β signaling in diseases

Cited by 266

Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo

Axmann, R., Böhm, C., Krönke, G., Zwerina, J., Smolen, J., & Schett, G. (2009) · Arthritis & Rheumatism

Bone Metabolism and DiseasesRheumatoid Arthritis Research and Therapies

Cited by 263

Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis

Akhmetshina, A., Dees, C., Pileckyte, M., Maurer, B., Axmann, R., Jüngel, A., Zwerina, J., Gay, S., Schett, G., Distler, O., et al. (2008) · The FASEB Journal

Systemic Sclerosis and Related DiseasesDupuytren's Contracture and Treatments

Cited by 187

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.

Schett, G., Redlich, K., Hayer, S., Zwerina, J., Bolon, B., Dunstan, C., Görtz, B., Schulz, A., Bergmeister, H., Kollias, G., et al. (2003) · Arthritis & Rheumatism

Bone Metabolism and DiseasesRheumatoid Arthritis Research and Therapies

Cited by 150

Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.

Redlich, K., Görtz, B., Hayer, S., Zwerina, J., Doerr, N., Kostenuik, P., Bergmeister, H., Kollias, G., Steiner, G., Smolen, J. S., et al. (2004) · The American Journal of Pathology

Rheumatoid Arthritis Research and TherapiesBone Metabolism and Diseases

Cited by 134

The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis

Reich, N., Maurer, B., Akhmetshina, A., Venalis, P., Dees, C., Zerr, P., Palumbo, K., Zwerina, J., Nevskaya, T., Gay, S., et al. (2010) · Arthritis & Rheumatism

Systemic Sclerosis and Related DiseasesDupuytren's Contracture and Treatments

Cited by 112

Synovial immunopathology in haemochromatosis arthropathy

Heiland, G. R., Aigner, E., Dallos, T., Sahinbegovic, E., Krenn, V., Thaler, C., Weiss, G., Distler, J. H., Datz, C., Schett, G., et al. (2010) · Annals of the Rheumatic Diseases

Iron Metabolism and DisordersOsteoarthritis Treatment and Mechanisms

Cited by 64

VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis

Nell-Duxneuner, V., Axmann, R., Husar-Memmer, E., Dallos, T., Datz, C., Stadlmayr, A., Aigner, E., Englbrecht, M., Schett, G., & Zwerina, J. (2013) · Annals of the Rheumatic Diseases

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 10

No Role of Osteocytic Osteolysis in the Development and Recovery of the Bone Phenotype Induced by Severe Secondary Hyperparathyroidism in Vitamin D Receptor Deficient Mice

Misof, B. M., Blouin, S., Hofstaetter, J. G., Roschger, P., Zwerina, J., & Erben, R. G. (2020) · International Journal of Molecular Sciences

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 9